April 9, 2018 / 5:18 AM / 3 months ago

Swiss speciality drugs company Polyphor announces plans to float

ZURICH, April 9 (Reuters) - Swiss speciality pharmaceuticals company Polyphor on Monday said it plans to raise 100 million to 150 million Swiss francs ($104.21 million to $156.32 million) by floating on the Swiss stock exchange.

The company said it would use the funds to develop Murepavadin, a drug to treat a strain of pneumonia with high levels of mortality. ($1 = 0.9596 Swiss francs) (Reporting by John Revill, editing by John Miller)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below